DWM
BIIB icon

Doyle Wealth Management’s Biogen BIIB Stock Holding History

Doyle Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-170
Closed -$40K – 257
2019
Q2 		$40K Buy
+170
New +$39.3K 0.01% 400
2019
Q1 		– Sell
-105
Closed -$32K – 247
2018
Q4 		$32K Buy
+105
New +$33.5K 0.01% 438

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Doyle Wealth Management's BIIB Position: Q3 2019 in Review

Doyle Wealth Management sold out of Biogen (BIIB) in Q3 2019, closing a stake of 170 shares — an estimated $40K sold.

Doyle Wealth Management first reported a position in BIIB in Q4 2018 and held it in 2 quarters. The position peaked at $40K in Q2 2019. 988 funds tracked by Wall St. Rank hold BIIB as of Q3 2019.

  • Doyle Wealth Management reported no remaining Biogen position as of Q3 2019 after selling out during the quarter.
  • Doyle Wealth Management sold 170 Biogen shares in Q3 2019, an estimated $40K.
  • Doyle Wealth Management first reported a position in Biogen in Q4 2018 and held it in 2 quarters.
  • Doyle Wealth Management's Biogen position peaked at $40K in Q2 2019.
  • 988 funds tracked by Wall St. Rank held Biogen as of Q3 2019.

Based on Doyle Wealth Management's 13F filing for Q3 2019, filed 5 Nov 2019.